Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

Get PFE alerts

About M. Dolsten

The proxy statement of Pfizer Inc reports total compensation of $9,743,289 for M. Dolsten in fiscal 2024, including a base salary of $1,654,300. Disclosed compensation is on record for 8 fiscal years. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.

Affiliation history

Company network

Current role

Drug Manufacturers - General · Healthcare

Leadership on record at Pfizer Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Pfizer Inc (PFE) $1,654,300 $9,743,289
2023 Pfizer Inc (PFE) $1,596,500 $8,858,700
2022 Pfizer Inc (PFE) $1,535,000 $12,218,233
2021 Pfizer Inc (PFE) $1,478,750 $10,914,990
2020 Pfizer Inc (PFE) $1,433,750 $10,149,624
2019 Pfizer Inc (PFE) $1,400,000 $9,598,045
2018 Pfizer Inc (PFE) $1,306,250 $7,070,199
2017 Pfizer Inc (PFE) $1,271,250 $7,670,815

Recent activity

No call appearances or filed executive changes recorded yet.